- Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q2 earnings results on Wednesday, August 6th, after market close.
- The consensus EPS Estimate is $0.14 and the consensus Revenue Estimate is $262.07M (+8.3% Y/Y).
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 9 downward. Revenue estimates have seen 3 upward revisions and 10 downward.
More on Acadia Pharma
- Acadia Pharmaceuticals: Another Legal Win, ACP-101 Readout Preview
- ACADIA Pharmaceuticals: Advancing On Several Fronts
- ACADIA Pharmaceuticals Inc. (ACAD) Q1 2025 Earnings Conference Call Transcript
- Acadia gets court approval related to Nuplazid patent
- Acadia Pharmaceuticals jumps after win in patent suit over Nuplazid